ABSTRACT
S-Adenosyl-L-methionine (SAMe) has been shown to regulate key cell functions. Abnormalities in SAMe content have been linked to the development of liver disease and to depression. This article reviews the biochemistry and functions of SAMe, its deficiency in liver disease and depression, and SAMe treatment in liver disease, depression, and osteoarthritis.
